GLP at UMSOM
The GLP Quality Assurance Office assists with compliance to GLP regulations for each organizational units either directly conducting GLP research or by research units providing support for GLP-related studies. Each research group conducting GLP-based research or providing services for GLP studies must be approved in advance for each GLP study. The office will assist and ensure the requirements can be met by the investigator’s organization.
Previous GLP Studies at UM
The University of Maryland, School of Medicine has had an active GLP program for more than 11 years. GLP related projects have been quite varied. For example some previous studies addressed the efficacy and mechanisms of action of medical countermeasures against radiological threats. Results from these studies resulted in FDA approval of a drug (Neulasta) for treatment of radiation injury. Other studies conducted at the University tested heart assist devices to be used in pediatric patients. More recently GLP studies into development of effective pretreatment of compounds for minimizing toxicity and lethality to exposure to nerve agents are ongoing.